As of 2024-12-15, the Relative Valuation of Pliant Therapeutics Inc (PLRX) is (96.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.30 USD, the upside of Pliant Therapeutics Inc based on Relative Valuation is -827.7%.
The range of the Relative Valuation is (91.08) - (97.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.1x - 30.8x | 29.2x |
| Forward P/E multiples | 27.5x - 29.3x | 29.2x |
| Fair Price | (91.08) - (97.18) | (96.78) |
| Upside | -784.8% - -830.7% | -827.7% |
| Date | P/E |
| 2024-12-13 | -4.01 |
| 2024-12-12 | -4.18 |
| 2024-12-11 | -4.28 |
| 2024-12-10 | -4.38 |
| 2024-12-09 | -4.48 |
| 2024-12-06 | -4.43 |
| 2024-12-05 | -4.31 |
| 2024-12-04 | -4.44 |
| 2024-12-03 | -4.41 |
| 2024-12-02 | -4.68 |
| 2024-11-29 | -4.16 |
| 2024-11-27 | -4.08 |
| 2024-11-26 | -4.02 |
| 2024-11-25 | -4.06 |
| 2024-11-22 | -3.92 |
| 2024-11-21 | -3.88 |
| 2024-11-20 | -3.84 |
| 2024-11-19 | -3.86 |
| 2024-11-18 | -3.72 |
| 2024-11-15 | -3.75 |
| 2024-11-14 | -3.88 |
| 2024-11-13 | -4.15 |
| 2024-11-12 | -4.17 |
| 2024-11-11 | -4.38 |
| 2024-11-08 | -4.53 |
| 2024-11-07 | -4.58 |
| 2024-11-06 | -4.74 |
| 2024-11-05 | -4.50 |
| 2024-11-04 | -4.37 |
| 2024-11-01 | -4.38 |
| 2024-10-31 | -4.25 |
| 2024-10-30 | -4.35 |
| 2024-10-29 | -4.44 |
| 2024-10-28 | -4.48 |
| 2024-10-25 | -4.27 |
| 2024-10-24 | -4.13 |
| 2024-10-23 | -4.29 |
| 2024-10-22 | -4.41 |
| 2024-10-21 | -4.42 |
| 2024-10-18 | -4.59 |
| 2024-10-17 | -4.43 |
| 2024-10-16 | -4.56 |
| 2024-10-15 | -4.22 |
| 2024-10-14 | -4.14 |
| 2024-10-11 | -4.12 |
| 2024-10-10 | -3.50 |
| 2024-10-09 | -3.46 |
| 2024-10-08 | -3.39 |
| 2024-10-07 | -3.36 |
| 2024-10-04 | -3.48 |